Table II.
DEGs in peripheral blood mononuclear cells from patients with KD prior to and following intravenous immunoglobulin therapy.
| Gene | Log fold change | P-value |
|---|---|---|
| PIGL | 1.73 | 1.13×10−18 |
| CXCR3 | 1.16 | 5.66×10−18 |
| MYL5 | 1.04 | 5.64×10−17 |
| ADAT2 | 1.14 | 2.06×10−16 |
| RBM3 | 1.91 | 7.68×10−16 |
| HKDC1 | 1.03 | 1.99×10−15 |
| TARBP1 | 1.17 | 3.04×10−15 |
| LOC791120 | 1.15 | 4.04×10−15 |
| IGH | 1.19 | 2.94×10−14 |
| TK1 | 1.04 | 5.89×10−14 |
| SPTA1 | 1.09 | 3.88×10−6 |
| RNF182 | 1.42 | 6.73×10−7 |
| ANXA3 | −2.60 | 4.80×10−24 |
| UPP1 | −1.75 | 2.85×10−23 |
| RAB24 | −1.10 | 3.35×10−23 |
| CD177 | −2.52 | 3.60×10−23 |
| CARD17 | −1.99 | 1.40×10−22 |
| S100A9 | −1.87 | 1.43×10−22 |
| FCGR1B | −2.46 | 2.45×10−22 |
| C19orf59 | −2.70 | 4.38×10−22 |
| S100A12 | −2.25 | 7.53×10−22 |
| LILRA5 | −1.55 | 1.31×10−21 |
| HSPA6 | −1.50 | 4.27×10−20 |
| CD59 | −1.42 | 4.92×10−20 |
| GALNT3 | −1.38 | 9.15×10−19 |
| TMEM49 | −1.04 | 4.52×10−18 |
| PPP1R3B | −1.43 | 7.36×10−18 |
| TIFA | −1.91 | 5.18×10−17 |
| TRIM25 | −1.19 | 5.94×10−17 |
| WDFY3 | −1.33 | 2.45×10−16 |
| KIF1B | −1.37 | 2.77×10−16 |
| CREB5 | −1.24 | 1.44×10−15 |
| PSTPIP2 | −1.48 | 2.53×10−15 |
| B4GALT5 | −1.24 | 3.15×10−15 |
| GAS7 | −1.29 | 4.45×10−15 |
| ACSL1 | −1.68 | 9.49×10−15 |
| KREMEN1 | −1.53 | 1.86×10−14 |
| IL8RA | −1.07 | 1.41×10−13 |
| CLEC2B | −1.49 | 1.71×10−13 |
| LRRK2 | −1.00 | 1.99×10−13 |
| CSTA | −1.30 | 6.85×10−12 |
| SCN9A | −1.04 | 1.36×10−11 |
| CEBPD | −1.26 | 8.96×10−11 |
| CLEC1A | −1.24 | 1.17×10−7 |
| NECAB1 | −1.05 | 6.29×10−7 |
| LRRN1 | −1.28 | 9.69×10−7 |
| LYVE1 | −1.31 | 1.02×10−5 |
These genes included top 10 differentially expressed genes and 28 differentially expressed genes that overlapped with target genes of differentially expressed microRNAs. DEGs, differentially expressed genes; KD, Kawasaki disease.